This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Arnold S. Relman, MD
Brigham and Women's Hospital Boston, Mass

JAMA. 1993;270(22):2683-2684.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Dr Rothman's criticisms¹ of the policies on financial conflict of interest of the New England Journal of Medicine (NEJM) are misguided and misinformed. I write as former editor of NEJM and the principal architect of its conflict of interest policies that have been continued by the current editors.

Contrary to Rothman's implication, manuscripts received by the NEJM are reviewed and decisions are made about publication without revealing anything about the conflict of interest to reviewers. Only after a paper is accepted for publication does the editor discuss disclosure with the author. This policy helps to ensure that manuscripts are reviewed on their merits. Acceptance means that the reviewers and editors have found no evidence of bias, so disclosure at the time of publication is not an implied "charge" or "allegation." It is simply acknowledgment of the existence of a financial relationship that might have had an . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?